Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan.

BACKGROUND & AIMS The NOD2 variants R702W, G908R, and L1007fsinsC are strongly associated with Crohn's disease (CD) in both European and American populations, but whether this susceptibility extends to all ethnic groups remains unknown. Except for the L1007fsinsC mutation, which produces a truncated NOD2 protein, the functional activity of the major CD-associated variants G908R and R702W is unknown. METHODS Individuals were genotyped for R702W, G908R, and L1007fsinsC. The ability of G908R, R702W, and L1007fsinsC variants in the presence and absence of P268S to confer responsiveness to lipopolysaccharide (LPS) and peptidoglycan (PGN) was determined in HEK293T kidney cells. RESULTS G908R and L1007fsinsC, but not R702W, were associated with disease susceptibility in Ashkenazi Jews. Ashkenazi Jews with CD had significantly higher allele frequency carriage of G908R and lower carriage of R702W compared with non-Jewish whites with CD. Functional studies revealed that the G908R, R702W, and L1007fsinsC variants in the presence and absence of P268S are defective in their ability to respond to bacterial LPS and PGN, whereas P268S alone exhibited wild-type activity. CONCLUSIONS R702W is not associated with susceptibility to CD in Ashkenazi Jews. The G908R, R702W, and L1007fsinsC variants share a common signaling defect in response to bacterial components, providing evidence for a unifying molecular mechanism whereby NOD2 mutations contribute to disease susceptibility.

[1]  C. O'Morain,et al.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. , 2002, American journal of human genetics.

[2]  Alastair Forbes,et al.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.

[3]  T. Ahmad,et al.  The molecular classification of the clinical manifestations of Crohn's disease. , 2002, Gastroenterology.

[4]  C. Janeway,et al.  RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems , 2002, Nature.

[5]  G. Cheng,et al.  Involvement of receptor-interacting protein 2 in innate and adaptive immune responses , 2002, Nature.

[6]  C. Elson.  Genes, microbes, and T cells--new therapeutic targets in Crohn's disease. , 2002, The New England journal of medicine.

[7]  James M. Wilson,et al.  Toll-Like Receptor 4 Mediates Innate Immune Responses to Haemophilus influenzae Infection in Mouse Lung1 , 2002, The Journal of Immunology.

[8]  Judy H. Cho,et al.  Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease , 2002, Clinical Microbiology Reviews.

[9]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[10]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[11]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[12]  J. Cavanaugh,et al.  International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. , 2001, American journal of human genetics.

[13]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[14]  J. Fox,et al.  Cutting Edge: Typhlocolitis in NF-κB-Deficient Mice1 , 2001, The Journal of Immunology.

[15]  Y. Ogura,et al.  Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides* , 2001, The Journal of Biological Chemistry.

[16]  S. Akira,et al.  Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.

[17]  E S Lander,et al.  Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. , 2000, American journal of human genetics.

[18]  D. Weeks,et al.  High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12. , 2000, American journal of human genetics.

[19]  S. Targan,et al.  A genome-wide search identifies potential new susceptibility loci for Crohn's disease , 1999 .

[20]  E. Rappaport,et al.  Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus – A GISC study , 1999, European Journal of Human Genetics.

[21]  S. Foster,et al.  Analysis of Peptidoglycan Structure from Vegetative Cells of Bacillus subtilis 168 and Role of PBP 5 in Peptidoglycan Maturation , 1999, Journal of bacteriology.

[22]  A Wajda,et al.  Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. , 1999, American journal of epidemiology.

[23]  L. Cardon,et al.  A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. , 1999, American journal of human genetics.

[24]  V. Binder,et al.  Genetic Epidemiology in Inflammatory Bowel Disease , 1998, Digestive Diseases.

[25]  L. Cardon,et al.  Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. , 1998, Gastroenterology.

[26]  E. Jabs,et al.  American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12. , 1998, Gastroenterology.

[27]  S. Foote,et al.  Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16 , 1998, Annals of human genetics.

[28]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[29]  J. Weber,et al.  Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Zinsmeister,et al.  Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. , 1998, Gastroenterology.

[31]  J. Terwilliger,et al.  Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 , 1996, Nature Genetics.

[32]  S. Targan,et al.  Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. , 1996, Human molecular genetics.

[33]  Jean Weissenbach,et al.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16 , 1996, Nature.

[34]  G. Nolan,et al.  Applications of retrovirus-mediated expression cloning. , 1996, Experimental hematology.

[35]  T. Mak,et al.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.

[36]  R. Sartor,et al.  Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. , 1993, Gastroenterology.

[37]  T. Sørensen,et al.  Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. , 1993, BMJ.

[38]  D. Podolsky,et al.  Inflammatory bowel disease (1) , 1991, The New England journal of medicine.

[39]  J. Rotter,et al.  Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. , 1989, Gastroenterology.

[40]  F. Majewski,et al.  The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. , 1989, American journal of medical genetics.